Zynerba Pharmaceuticals Reports First Quarter 2023 Financial ResultsĀ and Operational Highlights

Go back to Zynerba Pharmaceuticals Reports First Quarter 2023 Financial ResultsĀ and Operational Highlights
(NASDAQ: ZYNE) Delayed: 1.30 --0 (-0%)
Previous Close $1.30    52 Week High $21.56 
Open $0.25    52 Week Low $4.64 
Day High $1.30    P/E N/A 
Day Low $1.30    EPS $0.00 
Volume 65,263,395